Skip to main content
ConductScienceScienceDex

Scott Andrew Gerber

FY2026 NIH rank #10,736
Unclaimed recordClaim profile
  • R01 Holder
  • Translational
  • Early Career
  • Mentor
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10335803Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Surgery
  • Biochemistry
  • Microbiology & Immunology

NIH Funding · FY2026

Linked Award Amount
$1.9M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#10,736
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Scott Andrew Gerber. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$1.7M

3 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Scott Andrew Gerber as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA295861-02R01
    Targeting Intrinsic and Extrinsic Barriers to Treat Metastatic Pancreatic Cancer
    University of Rochester
    $639.1K
    award amount
  • 1R01CA300076-01A1R01
    Targeting T Cell Dynamics with IL12mRNA Nanotechnology-Enhanced SBRT to Overcome Immune Suppression in Pancreatic Cancer
    University of Rochester
    $624.5K
    award amount
  • 1R21CA300890-01A1R21
    Transcriptional co-activator PGC-1α promotes anti-tumor immunity in colorectal cancer
    University of Rochester
    $388.9K
    award amount
  • 5T32AI007285-39T32
    The T32 Predoctoral Training Program in Immunology (PTPI)
    University of Rochester
    $239.9K
    award amount

Award organization

Organizations that administered FY2026 awards listing Scott Andrew Gerber as a PI.

FY2026 award administered by University of Rochester (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Rochester
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    R01 Grant Holder
  5. 2026
    $2M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Scott Andrew Gerber.

Jacques Robert
University of Rochester
3
shared awards
Darren Richard Carpizo
University of Rochester
2
shared awards
David C Linehan
University of Rochester
2
shared awards

Explore further

Find collaborators for Scott Andrew Gerber

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →
Scott Andrew Gerber | NIH Award Records | ConductScience